Author:
Adami S.,Passeri M.,Ortolani S.,Broggini M.,Carratelli L.,Caruso I.,Gandolini G.,Gnessi L.,Laurenzi M.,Lombardi A.,Norbiato G.,Pryor-Tillotson S.,Reda C.,Romanini L.,Subrizi D.,Wei L.,Yates A.J.
Subject
Histology,Physiology,Endocrinology, Diabetes and Metabolism
Reference34 articles.
1. Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin;Adami;Osteoporosis Int,1993
2. Aminohydroxybutane bisphosphonate prevents bone loss in a rat model of simulated weightlessness;Apseloff;Carr Ther Res Clin Exp,1991
3. Aminohydroxybutane bisphosphonate and clenbuterol prevent bone changes and retard muscle atrophy respectively in tail-suspended rats;Apseloff;J Pharmacol Exp Ther,1993
4. Effects of aminohydroxybutane bisphosphonate on bone growth when administered after hind-limb bone loss in tail-suspended rats;Apseloff;J Pharmacol Exp Ther,1993
5. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates;Balena;J Clin Invest,1993
Cited by
120 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献